- Home
- MSPR vs REVB Comparison
MSPR vs REVB Comparison
Compare MSPR & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSPR
- REVB
- Stock Information
- Founded
- MSPR 2014
- REVB 2020
- Country
- MSPR United States
- REVB United States
- Employees
- MSPR N/A
- REVB N/A
- Industry
- MSPR
- REVB Biotechnology: Pharmaceutical Preparations
- Sector
- MSPR
- REVB Health Care
- Exchange
- MSPR NYSE
- REVB Nasdaq
- Market Cap
- MSPR 4.9M
- REVB 5.4M
- IPO Year
- MSPR N/A
- REVB N/A
- Fundamental
- Price
- MSPR $2.16
- REVB $0.40
- Analyst Decision
- MSPR
- REVB
- Analyst Count
- MSPR 0
- REVB 0
- Target Price
- MSPR N/A
- REVB N/A
- AVG Volume (30 Days)
- MSPR 203.5K
- REVB 6.8M
- Earning Date
- MSPR 11-14-2024
- REVB 11-08-2024
- Dividend Yield
- MSPR N/A
- REVB N/A
- EPS Growth
- MSPR N/A
- REVB N/A
- EPS
- MSPR N/A
- REVB N/A
- Revenue
- MSPR $10,734,000.00
- REVB N/A
- Revenue This Year
- MSPR $293,208.70
- REVB N/A
- Revenue Next Year
- MSPR N/A
- REVB N/A
- P/E Ratio
- MSPR N/A
- REVB N/A
- Revenue Growth
- MSPR 217.86
- REVB N/A
- 52 Week Low
- MSPR $1.43
- REVB $0.28
- 52 Week High
- MSPR $66.00
- REVB $25.26
- Technical
- Relative Strength Index (RSI)
- MSPR N/A
- REVB 39.87
- Support Level
- MSPR N/A
- REVB $0.39
- Resistance Level
- MSPR N/A
- REVB $0.53
- Average True Range (ATR)
- MSPR 0.00
- REVB 0.13
- MACD
- MSPR 0.00
- REVB 0.00
- Stochastic Oscillator
- MSPR 0.00
- REVB 7.54
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).